[go: up one dir, main page]

CH419127A - Verfahren zur Herstellung von substituierten 3-Pyrrolidinolen - Google Patents

Verfahren zur Herstellung von substituierten 3-Pyrrolidinolen

Info

Publication number
CH419127A
CH419127A CH152660A CH152660A CH419127A CH 419127 A CH419127 A CH 419127A CH 152660 A CH152660 A CH 152660A CH 152660 A CH152660 A CH 152660A CH 419127 A CH419127 A CH 419127A
Authority
CH
Switzerland
Prior art keywords
pyrrolidinols
substituted
preparation
Prior art date
Application number
CH152660A
Other languages
English (en)
Inventor
Hua Wu Yao
Frederick Feldkamp Rolland
Andrew Gould William
Original Assignee
Mead Johnson & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mead Johnson & Co filed Critical Mead Johnson & Co
Publication of CH419127A publication Critical patent/CH419127A/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J73/00Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J73/00Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/003Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by oxygen as hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
CH152660A 1959-02-12 1960-02-11 Verfahren zur Herstellung von substituierten 3-Pyrrolidinolen CH419127A (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79271259A 1959-02-12 1959-02-12
US2571A US3108117A (en) 1959-02-12 1960-01-15 3-benzyl-1, 2-diloweralkyl-3-pyrrolidinols

Publications (1)

Publication Number Publication Date
CH419127A true CH419127A (de) 1966-08-31

Family

ID=26670565

Family Applications (1)

Application Number Title Priority Date Filing Date
CH152660A CH419127A (de) 1959-02-12 1960-02-11 Verfahren zur Herstellung von substituierten 3-Pyrrolidinolen

Country Status (6)

Country Link
US (1) US3108117A (de)
BE (1) BE587542A (de)
CH (1) CH419127A (de)
DE (1) DE1445100A1 (de)
FR (1) FR1310459A (de)
GB (1) GB882813A (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5821622B2 (ja) * 1973-02-28 1983-05-02 ウェルファイド株式会社 ピロリジンメタノ−ル ノ セイゾウホウ
EP0586229A1 (de) * 1992-09-01 1994-03-09 Zeneca Limited 3-Hydroxy-3-(Subst.-Alkyl)-Pyrrolidine als 5-Lipoxygenase-Inhibitoren
US7638541B2 (en) 2006-12-28 2009-12-29 Metabolex Inc. 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
CA2693169C (en) 2007-07-19 2016-01-12 Metabolex, Inc. N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
KR20110026481A (ko) * 2008-06-20 2011-03-15 메타볼렉스, 인코포레이티드 아릴 gpr119 작동약 및 이의 용도
WO2011041154A1 (en) 2009-10-01 2011-04-07 Metabolex, Inc. Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts
CN109674753A (zh) 2010-06-23 2019-04-26 希玛贝治疗股份有限公司 固态分散体
US10292983B2 (en) 2016-08-03 2019-05-21 Cymabay Therapeutics, Inc. Oxymethylene aryl compounds for treating inflammatory gastrointestinal diseases or gastrointestinal conditions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2878264A (en) * 1959-03-17 Substituted amino alcohols

Also Published As

Publication number Publication date
BE587542A (fr) 1960-08-12
GB882813A (en) 1961-11-22
US3108117A (en) 1963-10-22
DE1445100A1 (de) 1969-01-16
FR1310459A (fr) 1962-11-30

Similar Documents

Publication Publication Date Title
CH370197A (de) Verfahren zur Herstellung von Actinospectacin
CH387047A (de) Verfahren zur Herstellung von Ketosidopurinen
CH400144A (de) Verfahren zur Herstellung von 16-Methylen-17a-hydroxy-progesteron-17-acylaten
CH419127A (de) Verfahren zur Herstellung von substituierten 3-Pyrrolidinolen
CH404962A (de) Verfahren zur Herstellung von Eupolyoxymethylenen
CH396026A (de) Verfahren zur Herstellung von Halogenalkylaminen
CH399742A (de) Verfahren zur Herstellung von Eupolyoxymethylenen
CH387606A (de) Verfahren zur Herstellung von Tetrahydroxydibor
CH440249A (de) Verfahren zur Herstellung von Polychlorbenzonitrilen
CH387029A (de) Verfahren zur Herstellung von 9a-Fluor-11B-oxy-16a-methylprogesteron
CH382165A (de) Verfahren zur Herstellung substituierter Pyrrolidinole
CH372297A (de) Verfahren zur Herstellung von 4-2-tert.-Aminomethyl-3-keto-steroiden
CH417595A (de) Verfahren zur Herstellung von Alkyl-5-alkylisoxazol-3-carboxylaten
CH538458A (de) Verfahren zur Herstellung von a-Dithiosemicarbazonen
CH380730A (de) Verfahren zur Herstellung von 4-Methoxy-2-methyl-6-sulfanilamidopyrimidin
CH416113A (de) Verfahren zur Herstellung von Eupolyoxymethylenen
CH387048A (de) Verfahren zur Herstellung von 7-Theophyllinderivaten
CH378344A (de) Verfahren zur Herstellung von 2-Amino-anthrachinonen
CH412841A (de) Verfahren zur Herstellung von 2-Trifluormethylbenzophenon
AT221092B (de) Verfahren zur Herstellung von substituierten 2-Oxo-benzochinolizinen
CH385849A (de) Verfahren zur Herstellung von substituierten 2-Oxobenzochinolizinen
AT217458B (de) Verfahren zur Herstellung von Chlorbenzonitrilen
AT221096B (de) Verfahren zur Herstellung von 2-Hydrazino-3-mercapto-chinoxalin
AT241484B (de) Verfahren zur Herstellung von Glucofuranosiden
AT221494B (de) Verfahren zur Herstellung von α-Amino-ω-lactamen